INTEGRATED BIOPHARMA INC Quarterly Debt-to-equity in % from Q1 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Integrated Biopharma Inc quarterly Debt-to-equity history and growth rate from Q1 2013 to Q3 2024.
  • Integrated Biopharma Inc Debt-to-equity for the quarter ending September 30, 2024 was 37.8 %, a 28.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 37.8 -15.2 -28.7% Sep 30, 2024
Q2 2024 39.6 -13.6 -25.6% Jun 30, 2024
Q1 2024 39.2 -14.4 -26.8% Mar 31, 2024
Q4 2023 52.6 +7.9 +17.7% Dec 31, 2023
Q3 2023 52.9 +1.48 +2.88% Sep 30, 2023
Q2 2023 53.2 -3.74 -6.57% Jun 30, 2023
Q1 2023 53.6 -14.3 -21% Mar 31, 2023
Q4 2022 44.7 -42.4 -48.7% Dec 31, 2022
Q3 2022 51.5 -62 -54.6% Sep 30, 2022
Q2 2022 56.9 -99.1 -63.5% Jun 30, 2022
Q1 2022 67.9 -148 -68.5% Mar 31, 2022
Q4 2021 87.1 -176 -66.9% Dec 31, 2021
Q3 2021 113 -216 -65.6% Sep 30, 2021
Q2 2021 156 -276 -63.9% Jun 30, 2021
Q1 2021 216 -384 -64% Mar 31, 2021
Q4 2020 263 -576 -68.7% Dec 31, 2020
Q3 2020 330 -982 -74.9% Sep 30, 2020
Q2 2020 432 -1.61K -78.8% Jun 30, 2020
Q1 2020 599 +3.18K Mar 31, 2020
Q4 2019 839 +1.61K Dec 31, 2019
Q3 2019 1.31K +1.78K Sep 30, 2019
Q2 2019 2.04K +2.38K Jun 30, 2019
Q1 2019 -2.58K -2.24K -660% Mar 31, 2019
Q4 2018 -773 -450 -139% Dec 31, 2018
Q3 2018 -468 -158 -51% Sep 30, 2018
Q2 2018 -344 -41.3 -13.6% Jun 30, 2018
Q1 2018 -340 -56.5 -20% Mar 31, 2018
Q4 2017 -323 -47 -17% Dec 31, 2017
Q3 2017 -310 -43.5 -16.3% Sep 30, 2017
Q2 2017 -303 -50.2 -19.9% Jun 30, 2017
Q1 2017 -283 -41.1 -17% Mar 31, 2017
Q4 2016 -276 -39.1 -16.5% Dec 31, 2016
Q3 2016 -266 -31.5 -13.4% Sep 30, 2016
Q2 2016 -253 -17.4 -7.4% Jun 30, 2016
Q1 2016 -242 -9.98 -4.3% Mar 31, 2016
Q4 2015 -237 -12.4 -5.5% Dec 31, 2015
Q3 2015 -235 -16.6 -7.58% Sep 30, 2015
Q2 2015 -235 -19.1 -8.83% Jun 30, 2015
Q1 2015 -232 -13.9 -6.34% Mar 31, 2015
Q4 2014 -224 -3.1 -1.4% Dec 31, 2014
Q3 2014 -218 +4.54 +2.04% Sep 30, 2014
Q2 2014 -216 +1.92 +0.88% Jun 30, 2014
Q1 2014 -218 -2.21 -1.02% Mar 31, 2014
Q4 2013 -221 Dec 31, 2013
Q3 2013 -223 Sep 30, 2013
Q2 2013 -218 Jun 30, 2013
Q1 2013 -216 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.